ID   PYRDB_LISMH             Reviewed;         304 AA.
AC   B8DDR9;
DT   28-JUL-2009, integrated into UniProtKB/Swiss-Prot.
DT   03-MAR-2009, sequence version 1.
DT   07-APR-2021, entry version 63.
DE   RecName: Full=Dihydroorotate dehydrogenase B (NAD(+)), catalytic subunit;
DE            Short=DHOD B;
DE            Short=DHODase B;
DE            Short=DHOdehase B;
DE            EC=1.3.1.14;
DE   AltName: Full=Dihydroorotate oxidase B;
DE   AltName: Full=Orotate reductase (NADH);
GN   Name=pyrD; OrderedLocusNames=LMHCC_0723;
OS   Listeria monocytogenes serotype 4a (strain HCC23).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Listeriaceae; Listeria.
OX   NCBI_TaxID=552536;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=HCC23;
RX   PubMed=21602330; DOI=10.1128/jb.05236-11;
RA   Steele C.L., Donaldson J.R., Paul D., Banes M.M., Arick T., Bridges S.M.,
RA   Lawrence M.L.;
RT   "Genome sequence of lineage III Listeria monocytogenes strain HCC23.";
RL   J. Bacteriol. 193:3679-3680(2011).
CC   -!- FUNCTION: Catalyzes the conversion of dihydroorotate to orotate with
CC       NAD(+) as electron acceptor. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(S)-dihydroorotate + NAD(+) = H(+) + NADH + orotate;
CC         Xref=Rhea:RHEA:13513, ChEBI:CHEBI:15378, ChEBI:CHEBI:30839,
CC         ChEBI:CHEBI:30864, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.3.1.14;
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210; Evidence={ECO:0000250};
CC       Note=Binds 1 FMN per subunit. {ECO:0000250};
CC   -!- PATHWAY: Pyrimidine metabolism; UMP biosynthesis via de novo pathway;
CC       orotate from (S)-dihydroorotate (NAD(+) route): step 1/1.
CC   -!- SUBUNIT: Heterotetramer of 2 PyrK and 2 PyrD type B subunits.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the dihydroorotate dehydrogenase family. Type 1
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP001175; ACK39078.1; -; Genomic_DNA.
DR   RefSeq; WP_003733086.1; NC_011660.1.
DR   SMR; B8DDR9; -.
DR   KEGG; lmh:LMHCC_0723; -.
DR   HOGENOM; CLU_042042_0_0_9; -.
DR   OMA; SCPHAKG; -.
DR   BioCyc; LMON552536:G1GTR-744-MONOMER; -.
DR   UniPathway; UPA00070; UER00945.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004152; F:dihydroorotate dehydrogenase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0004589; F:orotate reductase (NADH) activity; IEA:UniProtKB-EC.
DR   GO; GO:0006207; P:'de novo' pyrimidine nucleobase biosynthetic process; IEA:InterPro.
DR   GO; GO:0044205; P:'de novo' UMP biosynthetic process; IEA:UniProtKB-UniPathway.
DR   CDD; cd04740; DHOD_1B_like; 1.
DR   Gene3D; 3.20.20.70; -; 1.
DR   HAMAP; MF_00224; DHO_dh_type1; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR033888; DHOD_1B.
DR   InterPro; IPR005720; Dihydroorotate_DH.
DR   InterPro; IPR024920; Dihydroorotate_DH_1.
DR   InterPro; IPR012135; Dihydroorotate_DH_1_2.
DR   InterPro; IPR001295; Dihydroorotate_DH_CS.
DR   Pfam; PF01180; DHO_dh; 1.
DR   PIRSF; PIRSF000164; DHO_oxidase; 1.
DR   TIGRFAMs; TIGR01037; pyrD_sub1_fam; 1.
DR   PROSITE; PS00911; DHODEHASE_1; 1.
DR   PROSITE; PS00912; DHODEHASE_2; 1.
PE   3: Inferred from homology;
KW   Cytoplasm; Flavoprotein; FMN; NAD; Oxidoreductase; Pyrimidine biosynthesis.
FT   CHAIN           1..304
FT                   /note="Dihydroorotate dehydrogenase B (NAD(+)), catalytic
FT                   subunit"
FT                   /id="PRO_1000195050"
FT   NP_BIND         45..46
FT                   /note="FMN"
FT                   /evidence="ECO:0000250"
FT   NP_BIND         243..244
FT                   /note="FMN"
FT                   /evidence="ECO:0000250"
FT   NP_BIND         265..266
FT                   /note="FMN"
FT                   /evidence="ECO:0000250"
FT   REGION          69..73
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250"
FT   REGION          192..193
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        130
FT                   /note="Nucleophile"
FT   BINDING         21
FT                   /note="FMN"
FT                   /evidence="ECO:0000250"
FT   BINDING         45
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         99
FT                   /note="FMN"
FT                   /evidence="ECO:0000250"
FT   BINDING         127
FT                   /note="FMN"
FT                   /evidence="ECO:0000250"
FT   BINDING         127
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         165
FT                   /note="FMN"
FT                   /evidence="ECO:0000250"
FT   BINDING         191
FT                   /note="FMN; via carbonyl oxygen"
FT                   /evidence="ECO:0000250"
FT   BINDING         217
FT                   /note="FMN; via amide nitrogen"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   304 AA;  32237 MW;  D4E208644858218F CRC64;
     MNRLAVEIPG LSLKNPIMPA SGCFGFGQEY SKYYDLNELG AIMAKAVTPE PRLGNPTPRV
     AETASGMLNA IGLQNPGLEH VLAHELPFLE QFETPIIANV AGATEDDYVQ VCARIGESKA
     VKAIELNISC PNVKHGGIAF GTDPEVAHRL TKAVKNVATV PVYVKLSPNV ADIVSIAQAI
     EAAGADGLTM INTLLGMRID LKTRKPIIAN GTGGLSGPAI KPVAIRMIHQ VRAVSNIPII
     GMGGVQTVDD VLEFLIAGAD AVAVGTMNFT DPFICPKLIS ELPKRMDELG ISSLQELKKE
     RANQ
//
